About Us

Explore how nanobubble innovation is driving breakthroughs in cancer diagnosis and precision therapy.

About Us

Explore how nanobubble innovation is driving breakthroughs in cancer diagnosis and precision therapy.

Ultrasound imaging has the potential to provide life-saving diagnostic and therapeutic interventions to every patient. Unlike the resource-intensive MRI, PET, or CT technology, ultrasound is portable and cost effective yet exceptionally powerful.

Contrast media improves image quality in all diagnostic applications. Ultrasound has lagged behind.

Visano harnesses the power of nanomedicine and sound to bring precise
cancer diagnosis and theranostic potential to standard ultrasound technology. The new contrast media can target specific cell biomarkers, works for small parts, high frequency imaging modes and provides ondemand cavitation for drug-free treatment.
Nanobubbles Images

What We Do

Ultrasound imaging has the potential to provide life-saving diagnostic and therapeutic interventions to every patient. Unlike the resource-intensive MRI, PET, or CT technology, ultrasound is portable and cost effective yet exceptionally powerful.

Contrast media improves image quality in all diagnostic applications. Ultrasound has lagged behind.

Visano harnesses the power of nanomedicine and sound to bring precise
cancer diagnosis and theranostic potential to standard ultrasound technology. The new contrast media can target specific cell biomarkers, works for small parts, high frequency imaging modes and provides ondemand cavitation for drug-free treatment.

What We Do

Our mission is unlocking the full potential of ultrasound using a new type of contrast agent. With capability for cancer-specific accumulation and targeting biomarkers, the nanobubble technology brings molecular imaging to the forefront of ultrasound-based diagnosis. Noninvasive theranostic applications using the same platform can augment image-guided therapies and trigger potent immune reactions to help treat otherwise untreatable tumors.

Who We Are

With over 50 years of combined experience our founders bring expertise in molecular biology, nanomedicine, biomedical ultrasound, image-guided drug delivery and translation of technologies from bench to bedside.

Who We Are

With over 50 years of combined experience our founders bring expertise in molecular biology, nanomedicine, biomedical ultrasound, image-guided drug delivery and translation of technologies from bench to bedside.

James P. Basilion, Ph.D.

James P. Basilion, Ph.D.

Inventor, Co-founder​

Professor of Radiology & BME, CWRU​ ​
30+ years of experience in molecular oncology, translational tech​

Agata A. Exner, Ph.D.

Agata A. Exner, Ph.D.

Inventor, Co-founder​

Professor of Radiology & BME, CWRU
20+ years of experience in imaging and nanomedicine

Michael J. Haag, MS, MBA

Michael J. Haag, MS, MBA

Co-founder, Chief Executive Officer

20+ years of experience in technology commercialization.

Scroll to Top